Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK.

Allan HackshawSarah S CohenHeidi ReichertAnuraag R KansalKaren C ChungJoshua J Ofman

Published in: British journal of cancer (2021)

Adding an MCED blood test to recommended screening can potentially be an efficient strategy. Ongoing randomised studies are required for full efficacy and cost-effectiveness evaluations.

Keyphrases

clinical trial
papillary thyroid
open label
study protocol
copy number
randomized controlled trial
cross sectional
squamous cell carcinoma
gene expression
dna methylation
case control
placebo controlled
genome wide